What’s Inside:

  1. Deep Dive - What Does Animal Health Look Like in an Agentic World?

  2. Cattler Raises $2 Million to Scale AI-Native Cattle Operations Platform Across the Americas

  3. Ceva and Mitsui Consolidate Japan Animal Health Operations Into New Joint Venture

  4. Elanco Q1 2026 Revenue Rises 15% on Pet and Farm Animal Strength; Guidance Raised

  5. DOJ Settles Agri Stats Antitrust Case With Information-Sharing Restrictions

  6. Phibro Launches Sustainable Solutions Platform With VAXA Microalgae Partnership

  7. EW Group Enters Exclusive Negotiations to Acquire Olmix From Amadéite and Motion Equity Partners

Merck Animal Health has standardized on Agentforce Life Sciences as global "OneCRM," consolidating vet, pet owner, and producer engagement on Data 360 with feeds from prescriptions, microchips, and feeders. For veterinary practices, practical agent applications include automated appointment scheduling, prescription refill triage, MAH product ordering and inventory checks, compliance documentation, and structured client outreach for boosters and parasiticide cycles. Over 12 to 36 months, the deployment raises switching costs against Zoetis and Elanco by embedding MAH-linked workflows in clinic operations, while extending Salesforce's regulated life-sciences footprint beyond human pharma.

Cattler Raises $2 Million to Scale AI-Native Cattle Operations Platform Across the Americas

Cattler, an Argentine-founded cattle operations platform active across eight countries in the Americas, closed a $2 million round led by Homegrown Capital with participation from Grit Road Partners. The platform manages roughly one million head daily across feedlots and integrated agribusinesses, contrasting with CattleMax, the Texas-based, roughly $200-per-year cow-calf software from Cattlesoft focused on US ranchers. Capital favors intensive operations and Latin American producers, and over 12 to 36 months the data layer should compound network effects strategics pay premiums to acquire.

Ceva and Mitsui Consolidate Japan Animal Health Operations Into New Joint Venture

France's Ceva and Japanese trading house Mitsui will merge Ceva Japan with 75-year-old Bussan Animal Health, with Mitsui transferring 60% of BAH and taking added equity in the French parent. This shifts the prior 2022 Ceva Bussan K.K., which served as a marketing and business-development vehicle, into an operational platform with consolidated sales coverage of Japanese veterinary clinics. Over 12 to 36 months, expect accelerated rollout of Ceva's livestock and companion pipeline, margin pickup from removed channel duplication, and pressure on smaller Japanese distributors.

Elanco Q1 2026 Revenue Rises 15% on Pet and Farm Animal Strength; Guidance Raised

Q1 revenue reached $1.371 billion, up 15% headline and 10% organic constant currency, with adjusted EBITDA of $334 million at 24.5% margin and adjusted EPS of $0.40 beating consensus. Credelio Quattro share gains, Zenrelia reaching blockbuster status, and Farm Animal double-digit growth supported a raised full-year guide of $5.01 to $5.085 billion and a $1.2 billion innovation target. Net leverage tightened to 3.5x with year-end target now 3.0x to 3.2x, putting Elanco within reach of sub-3.0x by 2027 and creating optionality for bolt-on M&A or capital return.

DOJ Settles Agri Stats Antitrust Case With Information-Sharing Restrictions

Agri Stats, the Indiana benchmarking firm aggregating processor-level price, cost, and output data for chicken, pork, and turkey, agreed to end sales report books and open most reports to buyers. The firm drew DOJ scrutiny because its decades-old, processor-only exchange covered most US poultry and pork volume, providing the structural mechanism alleged to enable coordinated pricing and output decisions. A court-appointed monitor, three-processor minimums, and timeliness curbs materially reduce signal value, removing a long-standing visibility tool for Tyson, Pilgrim's, JBS, Hormel, and Smithfield as the DOJ beef probe escalates.

Phibro Launches Sustainable Solutions Platform With VAXA Microalgae Partnership

Phibro Animal Health unveiled its Sustainable Solutions Platform anchored by VERRATAIN, a master sustainability brand initially supplied by VAXA Technologies, an Iceland-based geothermal-powered indoor microalgae cultivator. Initial offerings VERRATAIN Spirulina and VERRATAIN Omega Oil are low-carbon feed materials with GHG Protocol-aligned life cycle assessments, designed to deliver Scope 3 reductions for protein, dairy, and petfood producers. Over 12 to 36 months Phibro positions a verifiable decarbonization line alongside its MFA business and acquired Zoetis portfolio, addressing Scope 3 pledges that lacked economically viable feed-side levers.

EW Group Enters Exclusive Negotiations to Acquire Olmix From Amadéite and Motion Equity Partners

EW Group, the German family-held life sciences holding behind Aviagen broiler genetics, Lohmann layers, and EW Nutrition, will acquire Brittany-based Olmix from founder vehicle Amadéite and France's Motion Equity Partners. Olmix's portfolio centers on marine algae extracts: Algimun and MSP-branded immune and gut-health additives, MT.X+ mycotoxin binders, plant-based animal nutrition, biosecurity hygiene lines, and crop biostimulants. Olmix runs standalone alongside EW Nutrition, giving EW a natural-additive and mycotoxin franchise to cross-sell into its poultry genetics and feed channels as antibiotic alternatives gain regulatory tailwinds

More From Protein Signals